Thanks bruh, I appreciate yall Progress Pictures 5/27/2025
The user experienced hair growth improvement using a 1.25mm microneedle weekly, oral finasteride, oral minoxidil, and rosemary oil. They plan to switch to generic finasteride and minoxidil for safety concerns.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity 10month fin/min - micro-needling and rosemary biotin & more
The conversation discusses a hair loss treatment routine involving daily minoxidil, finasteride, micro-needling, rosemary oil, and biotin supplements. The user shares personal experiences, noting no side effects from finasteride and emphasizing the importance of a healthy lifestyle in preventing hair loss.
community 4 Month Progress (Min/Fin Oral, Micro-needling + Rosemary Oil every 4 days)
The user experienced significant hair regrowth over four months using oral finasteride, oral minoxidil, micro-needling, and rosemary oil. They reported no side effects and emphasized the importance of continuing the treatment to maintain results.
community 10 weeks on 0.25mg fin daily + collagen + biotin supps
User experienced hair regrowth and no side effects after 10 weeks on 0.25mg finasteride daily, along with biotin, collagen, micro-needling, and hair oil. They stopped minoxidil due to inconvenience and noticed initial shedding but now see more fullness.
community About 10 months on fin and 7 months using min
A user shared progress pictures after 10 months on finasteride and 7 months using minoxidil, noting some hair shedding. Their routine includes oral finasteride, topical minoxidil, red light therapy, rosemary mint shampoo, and dermarolling.
community 24 days progress, essential oils + microneedling, no min/fin
The user experienced hair loss due to androgenic alopecia and chose to use essential oils (rosemary and peppermint) and microneedling instead of minoxidil or finasteride. They reported positive results after 24 days and plan to continue with these treatments.
Related Research
6 / 6 resultsresearch 75712 Clinical Effectiveness of Complementary and Alternate Therapies for Androgenetic Alopecia
Rosemary oil may be a promising and affordable treatment for hair loss.
research Phytochemicals and novel delivery systems in alopecia management: An integrative review
This review summarizes recent advances in alopecia management, focusing on combining synthetic and herbal therapies with innovative drug delivery systems like nanocarriers to enhance effectiveness and reduce side effects, while noting challenges with skin penetration and bioavailability.
research A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.
research Androgenetic Alopecia: Therapy Update
This comprehensive review analyzes androgenetic alopecia treatments, discussing the mechanisms, costs, efficacy, and safety of FDA-approved drugs like minoxidil and finasteride, as well as newer non-FDA-approved options that have shown effectiveness across various studies.
research Novel Strategies for Androgenetic Alopecia Therapy: Integrating Multifunctional Plant Extracts with Nanotechnology for Advanced Cutaneous Drug Delivery
This review examines recent advances in androgenetic alopecia treatment, highlighting how multifunctional plant extracts combined with nanotechnology could improve topical therapy efficacy by enhancing local drug bioavailability and targeting, addressing limitations of existing treatments.
research Clinical and preclinical approach in AGA treatment: a review of current and new therapies in the regenerative field
This review discusses current and emerging therapies for androgenetic alopecia, emphasizing regenerative treatments and nanotechnology advancements, but it reports no new clinical results.